IFNA2 Protein
Quick Overview for IFNA2 Protein (ABIN2830540)
Target
See all IFNA2 ProteinsProtein Type
Biological Activity
Origin
Source
Application
Purity
- 
    
- 
                                            
Sequence
 - CDLPQTHSLG SRRTLMLLAQ MRRISLFSCL KDRHDFGFPQ EEFGNQFQKA ETIPVLHEMI QQIFNLFSTK DSSAAWDETL LDKFYTELYQ QLNDLEACVI QGVGVTETPL MKEDSILAVR KYFQRITLYL KEKKYSPCAW EVVRAEIMRS FSLSTNLQES LRSKE
 - 
                                            
Characteristics
 - Biological Activity: Fully biologically active when compared to standard. The specific activity determined by an anti-viral assay is no less than 1.6 x 108 IU/mg.
 - 
                                            
Sterility
 - 0.2 μm filtered
 
 - 
                                            
 - 
    
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
 - 
    
 - 
    
- 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Buffer
 - PBS, pH 7.4, with 0.02 % Tween-20
 - 
                                            
Storage
 - -20 °C
 
 - 
                                            
 - 
    
- IFNA2 (Interferon, alpha 2 (IFNA2))
 - 
                                            
Alternative Name
 - IFNA2
 - 
                                            
Background
 - 
                        Relevance: Produced by macrophages, IFN-alpha have antiviral activities.
Synonyms: IFN-alpha-2, LeIF A - 
                                            
Molecular Weight
 - 19.3 kDa
 - 
                                            
UniProt
 - P01563
 - 
                                            
Pathways
 - JAK-STAT Signaling, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
 
Target
 -